Items where Author is "Filiz, E. S."
![[up]](/style/images/multi_up.png)
Up a level
Filiz, E. S., Stringer, D., Kellermann, V. 
ORCID: 0009-0004-5969-3769 , Olive, R. R., Said, O., Mutwalli, H., Bektas, S., Akkese, M. N., Ireland, K., Beishon-Murley, D., Khor, J. W. T., Allman, L., Kotze, N., Carter, B., Tyrrell-Bunge, E., Rowlands, K., Keeler, J. L., Ivin, G., Simic, M., Sually, D. S., Bentley, J., Young, A. H., Madden, S., Byford, S., Landau, S., Treasure, J., Schmidt, U., Nicholls, D., Lawrence, V. & Himmerich, A. H. (2026).
Olanzapine for young people with anorexia nervosa: a synopsis of the main results from the OPEN open-label feasibility study.
Health Technology Assessment, 30(36),
doi: 10.3310/gjhh0812
Olive, R. R., Kellermann, V. ORCID: 0009-0004-5969-3769, Said, O. , Filiz, E. S., Treasure, J., Schmidt, U., Bentley, J., Khor, J. W. T., Simic, M., Nicholls, D., Himmerich, H. & Lawrence, V. (2025).
What does taking olanzapine mean to young people with anorexia nervosa and their families? Findings from the OPEN feasibility trial.
Journal of Eating Disorders, 13(1),
article number 228.
doi: 10.1186/s40337-025-01401-z